16 -9 (71) 2024 - Akhmedova M.Dj., Mirzajonova D.B. - THE MODERN ASPECTS OF SHIGELLOSIS

THE MODERN ASPECTS OF SHIGELLOSIS

Akhmedova M.Dj. - Tashkent Medical Academy

Mirzajonova D.B. - Tashkent Medical Academy, The Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious Diseases and Parasitic Diseases

Ruziev A.M. - Tashkent Medical Academy, The Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious Diseases and Parasitic Diseases

Resume

Acute intestinal infections, including bacterial shigellosis, are a major endemic infection in children 1–5 years of age living in low- and middle-income countries. Shigellosis causes about 164,000 deaths each year, according to the World Health Organization. Currently, the emergence of multiresistant strains of Shigella to antibiotics is due to the uncontrolled use of antibiotics. This forces us to reconsider treatment tactics. This article presents analytical data from scientific research by a number of scientists. This, in turn, may prompt a revision of treatment tactics.

Keywords: Shigellosis, shigella, dysentery, hemocolitis, acute diarrhea

First page

76

Last page

82

For citation:Akhmedova M.Dj., Mirzajonova D.B., Ruziev A.M. - THE MODERN ASPECTS OF SHIGELLOSIS//New Day in Medicine 9(71)2024 76-82 https://newdayworldmedicine.com/en/new_day_medicine/9-71-2024

List of References

  1. Sujit K. Bhattacharya, Dipika Sur, L von Seidlein, Shigellosis, Reference Module in Biomedical Sciences, Elsevier, 2023.
  2. Niyogi, Swapan Kumar. "Shigellosis." //The journal of microbiology 43.2 (2005): 133-143.
  3. K. Shi Observations on the epidemiology of dysentery in Japan Phil J Sci, 1 (1906), pp. 485-500;
  4. Kotloff, Karen L., et al. "Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. //Bulletin of the World Health Organization 1999;77.8:651.
  5. Валиев A.Г., Каримова Ш.М. Aхмедова М.Д. Современное состояние острых кишечных инфексий: диагностика, клиника и прогноз // Инф, иммунитет и фармакология. 2004;1:117-119.
  6. Халит С.Х., Семёнова Д.Р. Клинико-епидемиологические особенности кишечных инфексий, протекающих с синдромом гемоколита, у детей //Педиатрия. 2011;3:12-16.
  7. Мадияров Р.С., Aхмедова М.Д., Ибадова Г.A. Высеваемост и видовая структура бактерий рода Шигелла у болных острыми диареями в некоторых регионах Республики Узбекистан // Инф, иммунитет и фармакология. 2006;2:56-58.
  8. Sujit K. Bhattacharya, Dipika Sur, L von Seidlein, Shigellosis, Reference Module in Biomedical Sciences, Elsevier, 2023
  9. Gorden Jed, and PL302732 Small. "Acid resistance in enteric bacteria. //Infection and immunity 1993; 61.1:364-367.
  10. Schroeder, Gunnar N., and Hubert Hilbi. "Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion //Clinical microbiology reviews 2008;21.1:134-156.
  11. Roehrich, A. Dorothea, et al. "The extreme C terminus of Shigella flexneri IpaB is required for regulation of type III secretion, needle tip composition, and binding. //Infection and immunity 2010;78.4:1682-1691.
  12. Schroeder, Gunnar N., Naja J. Jann, and Hubert Hilbi. "Intracellular type III secretion by cytoplasmic Shigella flexneri promotes caspase-1-dependent macrophage cell death. //Microbiology 2007;153.9:2862-2876.
  13. Suzuki Toshihiko, et al. "A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages. //Journal of Biological Chemistry 2005;280.14:14042-14050.
  14. Blocker, Ariel, Kaoru Komoriya, and Shin-Ichi Aizawa. "Type III secretion systems and bacterial flagella: insights into their function from structural similarities. //Proceedings of the National Academy of Sciences 2003;100.6:3027-3030.
  15. Ashida Hiroshi, et al. "Shigella are versatile mucosal pathogens that circumvent the host innate immune system. //Current opinion in immunology 2011;23.4:448-455.
  16. Schroeder, Gunnar N., and Hubert Hilbi. "Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. //Clinical microbiology reviews 2008;21.1:134-156.
  17. Philpott Dana J., et al. "Invasive Shigella flexneri activates NF-κB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. //The Journal of Immunology 2000;165.2:903-914.
  18. Roehrich A. Dorothea et al. "The extreme C terminus of Shigella flexneri IpaB is required for regulation of type III secretion, needle tip composition, and binding. //Infection and immunity 2010;78.4:1682-1691.
  19. Blocker Ariel, Kaoru Komoriya, and Shin-Ichi Aizawa. "Type III secretion systems and bacterial flagella: insights into their function from structural similarities. //Proceedings of the National Academy of Sciences 2003;100.6:3027-3030.
  20. Philpott, Dana J., et al. "Invasive Shigella flexneri activates NF-κB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. //The Journal of Immunology 2000;165.2:903-914.

    file

    download